Home LiteratureArticle Details
PMID: 18462347 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes.

Immunology ·Vol. 125 ·No. 3 ·2008-11-00 ·Pages 408-19

Orlowski RJ, O'Rourke KS, Olorenshaw I, Hawkins GA, Maas S, Laxminarayana D

Abstract

The aetiopathogenesis of the abnormal immune response in systemic lupus erythematosus (SLE) remains incompletely understood. We and other investigators demonstrated altered expression of adenosine deaminase that act on RNA (ADAR) genes in SLE patients. Based on this information, we hypothesize that the altered expression and function of ADAR enzymes is a mechanism for the immunopathogenesis of SLE. ADARs edit gene transcripts through site-specific conversion of adenosine to inosine by hydrolytic deamination at C6 of the adenosine. Thirteen SLE subjects and eight healthy controls were studied. We assessed the role of ADAR enzymes in editing of PDE8A1 gene transcripts of normal and SLE T cells. These studies demonstrated the occurrence of ADAR-catalysed altered and site-selective editing profile of specific sites in the PDE8A1 gene transcripts of normal and SLE T cells. Two hot spots for A to I editing were observed in the PDE8A1 transcripts of normal and SLE T cells. A fundamental finding of this study is A to I hypo-editing followed by up-regulation of PDE8A1 transcripts in SLE T cells. These results are confirmed by analysing PDE8A1 transcripts of normal T cells activated with type I interferon-alpha. It is proposed that, the altered expression of ADAR enzymes tilt the balance of editing machinery and alter editing in SLE transcriptome. Such altered editing may contribute to the modulation of gene regulation and ultimately, immune functions in SLE and play an important role in the initiation and propagation of SLE pathogenesis.

MeSH Terms
3',5'-Cyclic-AMP Phosphodiesterases/genetics,immunology Adult Base Sequence Cells, Cultured Female Humans Immunophenotyping Interferon-alpha/immunology Lupus Erythematosus, Systemic/genetics,immunology Lymphocyte Activation/immunology Male Middle Aged Molecular Sequence Data Mutation Polymerase Chain Reaction/methods Polymorphism, Single Nucleotide RNA Editing RNA, Messenger/genetics T-Lymphocytes/immunology Transcription, Genetic Up-Regulation/immunology
Chemicals
Interferon-alpha RNA, Messenger 3',5'-Cyclic-AMP Phosphodiesterases PDE8A protein, human
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Orlowski Robert J
Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
O'Rourke Kenneth S
Olorenshaw Irene
Hawkins Gregory A
Maas Stefan
Laxminarayana Dama
References (51)
51 references, click to expand
  1. An etiopathogenic role for the type I IFN system in SLE.
    Trends Immunol. 2001 Aug;22(8):427-31 PMID: 11473831
  2. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.
    Science. 1994 Dec 9;266(5191):1709-13 PMID: 7992055
  3. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.
    Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11457-61 PMID: 7972084
  4. Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes.
    Lancet. 2002 Sep 14;360(9336):842-9 PMID: 12243919
  5. SUMO-1 modification alters ADAR1 editing activity.
    Mol Biol Cell. 2005 Nov;16(11):5115-26 PMID: 16120648
  6. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.
    Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14687-92 PMID: 11717408
  7. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14869-74 PMID: 9843982
  8. Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28.
    Immunology. 2007 Dec;122(4):623-33 PMID: 17897325
  9. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.
    Cell. 1991 Oct 4;67(1):11-9 PMID: 1717158
  10. A-to-I RNA editing: recent news and residual mysteries.
    J Biol Chem. 2003 Jan 17;278(3):1391-4 PMID: 12446659
  11. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    J Biol Chem. 2004 Feb 6;279(6):4941-51 PMID: 14660658
  12. A mammalian RNA editing enzyme.
    Nature. 1996 Feb 1;379(6564):460-4 PMID: 8559253
  13. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing.
    J Biol Chem. 2005 Apr 15;280(15):15020-8 PMID: 15677478
  14. Cross-regulation of TNF and IFN-alpha in autoimmune diseases.
    Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3372-7 PMID: 15728381
  15. RNA editing by adenosine deaminases that act on RNA.
    Annu Rev Biochem. 2002;71:817-46 PMID: 12045112
  16. Systemic lupus erythematosus.
    Cell. 1996 May 3;85(3):303-6 PMID: 8616885
  17. Systematic identification of abundant A-to-I editing sites in the human transcriptome.
    Nat Biotechnol. 2004 Aug;22(8):1001-5 PMID: 15258596
  18. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites.
    Gene. 2005 Dec 19;363:193-201 PMID: 16297572
  19. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome.
    PLoS Biol. 2004 Dec;2(12):e391 PMID: 15534692
  20. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
    Arthritis Rheum. 1992 Jun;35(6):630-40 PMID: 1599520
  21. Sporadic ALS: blame it on the editor.
    Nat Med. 2004 Apr;10(4):347 PMID: 15057227
  22. Widespread RNA editing of embedded alu elements in the human transcriptome.
    Genome Res. 2004 Sep;14(9):1719-25 PMID: 15342557
  23. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.
    J Clin Invest. 1979 May;63(5):885-92 PMID: 312809
  24. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia.
    Mol Psychiatry. 2001 Jul;6(4):373-9 PMID: 11443520
  25. Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution.
    Gene. 2001 Dec 12;280(1-2):183-94 PMID: 11738832
  26. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14875-9 PMID: 9843983
  27. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.
    Arthritis Rheum. 1998 Oct;41(10):1714-24 PMID: 9778212
  28. Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
    Pediatr Allergy Immunol. 2006 Dec;17(8):565-71 PMID: 17121583
  29. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Immunology. 2007 Jul;121(3):359-69 PMID: 17376196
  30. Microarray analysis of gene expression in lupus.
    Arthritis Res Ther. 2003;5(6):279-87 PMID: 14680503
  31. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing.
    Science. 2005 Sep 2;309(5740):1534-9 PMID: 16141067
  32. Glutamate receptors: RNA editing and death of motor neurons.
    Nature. 2004 Feb 26;427(6977):801 PMID: 14985749
  33. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
    Science. 2007 Feb 23;315(5815):1137-40 PMID: 17322061
  34. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    J Mol Med (Berl). 2005 Feb;83(2):110-20 PMID: 15624111
  35. RNA editing minireview series.
    J Biol Chem. 2003 Jan 17;278(3):1389-90 PMID: 12446658
  36. Specific cleavage of hyper-edited dsRNAs.
    EMBO J. 2001 Aug 1;20(15):4243-52 PMID: 11483527
  37. Identification and classification of conserved RNA secondary structures in the human genome.
    PLoS Comput Biol. 2006 Apr;2(4):e33 PMID: 16628248
  38. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations.
    J Autoimmun. 2004 Dec;23(4):371-8 PMID: 15571931
  39. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
    Nature. 1997 May 15;387(6630):303-8 PMID: 9153397
  40. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):6319-24 PMID: 11371644
  41. Regulation of alternative splicing by RNA editing.
    Nature. 1999 May 6;399(6731):75-80 PMID: 10331393
  42. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.
    Neuron. 2002 Apr 25;34(3):349-56 PMID: 11988167
  43. RNA editing at the Q/R site for the glutamate receptor subunits GLUR2, GLUR5, and GLUR6 in hippocampus and temporal cortex from epileptic patients.
    Neurobiol Dis. 2001 Jun;8(3):459-68 PMID: 11442354
  44. The role of RNA editing of kainate receptors in synaptic plasticity and seizures.
    Neuron. 2001 Jan;29(1):217-27 PMID: 11182093
  45. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases.
    Nucleic Acids Res. 1996 Sep 15;24(18):3546-51 PMID: 8836181
  46. Control of human potassium channel inactivation by editing of a small mRNA hairpin.
    Nat Struct Mol Biol. 2004 Oct;11(10):950-6 PMID: 15361858
  47. Regulating gene expression through RNA nuclear retention.
    Cell. 2005 Oct 21;123(2):249-63 PMID: 16239143
  48. Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans.
    Cell Signal. 2003 Jun;15(6):565-74 PMID: 12681444
  49. RNA editing: rewriting receptors.
    Curr Biol. 1997 Jul 1;7(7):R437-9 PMID: 9210370
  50. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7906-11 PMID: 12048240
  51. Altered adenosine-to-inosine RNA editing in human cancer.
    Genome Res. 2007 Nov;17(11):1586-95 PMID: 17908822
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
1365-2567
Published
2008-11-00
Epub
2008-00-06
Pages
408-19
Language
English
Region
England
NLM ID
0374672
PMCID
PMC2669144
Subset
IM
Grants
NCRR NIH HHS · M01 RR007122 · United States
NIAMS NIH HHS · R01 AR048628 · United States
NCRR NIH HHS · M01 RR07122 · United States
NIAMS NIH HHS · R01-AR48628 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com